Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-20-061712

Director sold 33,750 shares at an average $151.32 ($5,107,148)

  • Director acquired 33,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hindson Benjamin J. · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-01 Exercise or conversion : show line 1 in the form +33,750 $0.88 $29,700 101,250 D
2020-12-01 Sale : show line 2 in the form −10,483 $150.07 $1,573,138 90,767 D
2020-12-01 Sale : show line 3 in the form −11,113 $150.92 $1,677,223 79,654 D
2020-12-01 Sale : show line 4 in the form −4,619 $151.84 $701,334 75,035 D
2020-12-01 Sale : show line 5 in the form −4,700 $153.14 $719,772 70,335 D
2020-12-01 Sale : show line 6 in the form −2,835 $153.68 $435,682 67,500 D
Open-market sales · 33,750 sh · avg $151.32 · $5,107,148

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-12-01 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −33,750 $0.88 2025-10-27 33,750 45,000 D
Loading xslF345X03/doc4.xml…